Trade MerckCo USA MRK

Sell
 Buy

MerckCo live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

MerckCo News

Sophia Claire 2025 Dec 05, 00:01

Trump's Fed Chair Pick: Power Plays and Monetary Policy in 2025

Noah Lee 2025 Dec 05, 00:00

Diverging Fed Rate Hike Expectations: Will the Fed Defy Forecasts?

Sophia Claire 2025 Dec 05, 00:00

PC Prices Projected to Surge by 2026 Amid AI-Driven Memory Shortage

Noah Lee 2025 Dec 05, 00:00

Gold Outlook 2026: Analyzing Scenarios and Potential Market Impacts

Noah Lee 2025 Dec 05, 00:00

Gold Nears Fair Value Amid Fed Uncertainty: Analyst Outlook

Ghko B 2025 Dec 04, 16:00

Bitcoin price prediction: BTC/USD rebounds, is BTC expected to rise further?

Ghko B 2025 Dec 04, 16:00

Nio stock price prediction: NIO jumps today, will this rally accelerate?

Ghko B 2025 Dec 03, 16:00

Stock opportunities for 2026: TSMC Stock, CRCL Stock, IONQ Stock, NIO

Ghko B 2025 Dec 03, 16:00

Best S&P 500 ETF to buy: Vanguard S&P 500 ETF (VOO), SPY, IVV, iShares ETFs

Ghko B 2025 Dec 03, 16:00

Best CFD Brokers: Award-winning CFD Platforms, markets.com, IG, Pepperstone

Latest news

Show more
Noah Lee 2025 Dec 05, 17:40

Polymarket Builds Internal Market-Making Team Amid Regulatory Scrutiny

Noah Lee 2025 Dec 05, 16:30

Poland's Crypto Regulation Stalled: MiCA Alignment Implications

Emma Rose 2025 Dec 05, 15:50

Do Kwon Faces Potential 12-Year Prison Sentence in Terraform Labs Collapse

Liam James 2025 Dec 05, 15:10

Texas Buys Bitcoin: Long-Term Strategy or Short-Term Gamble?

Noah Lee 2025 Dec 05, 13:40

Beyond 'Buy the Dip': Institutional Crypto Investment Strategies

Noah Lee 2025 Dec 05, 13:10

The Future of Web3 Wallets: 5 Key Areas of Focus

Sophia Claire 2025 Dec 05, 12:50

Solana Presale Plagued by Bot Attack: WET Token Launch Scrapped

Noah Lee 2025 Dec 05, 12:20

Paribu Acquires CoinMENA: A Strategic Move into the MENA Crypto Market

Info

Spread

0.61

Spread (%)

0.6147 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Friday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

252001353728

Shares Outstanding

2482022536

Earnings Date (Next)

2021-06-03

Div Yield

2026-01-08

Ex-Dividend Date

2025-12-15

Forward annual dividend rate

3.4

Forward annual dividend yield

0.0332

EPS

7.56

Learn more about this instrument

MerckCo USA Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Dec 04, 16:00

How to trade gold: Trading tips on gold CFDs, Short-term trades in XAU/USD

Ghko B 2025 Dec 03, 16:00

What are the most traded indices: how to trade indices CFD with markets.com?

Ghko B 2025 Dec 03, 16:00

Start investing in 2026: trader's guide, how to find the best CFD broker?

Trustpilot